Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrea Phillips-Beyer
Observed names:
A. Phillips-Beyer,
Andrea Phillips‑Beyer,
Phillips-Beyer, Andrea
ORCID:
0000-0003-3927-4319
Observed ORCID:
0000-0003-3927-4319
OpenAlex ID:
A5069099491
Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)
2020
·
Stacie Hudgens
, Andrea Phillips-Beyer
, et al.
·
Patient
·
44
PDF
Benefit–Risk or Risk–Benefit Trade-Offs? Another Look at Attribute Ordering Effects in a Pilot Choice Experiment
2020
·
Sebastian Heidenreich
, Andrea Phillips-Beyer
, et al.
·
Patient
·
37
Preferences of patients for benefits and risks of insomnia medications using data elicited during two phase III clinical trials
2022
·
Sebastian Heidenreich
, Melissa Ross
, et al.
·
SLEEP
·
18
PDF
Treatment preferences in relation to fatigue of patients with relapsing multiple sclerosis: A discrete choice experiment
2023
·
Tommi Tervonen
, Robert J Fox
, et al.
·
Multiple Sclerosis Journal - Experimental Translational and Clinical
·
11
PDF
Meaningful Within-Patient Change in Subjective Total Sleep Time in Patients with Insomnia Disorder: An Analysis of the Sleep Diary Questionnaire Using Data from Open-Label and Phase III Clinical Trials
2024
·
Andrea Phillips-Beyer
, Ariane K. Kawata
, et al.
·
Pharmaceutical Medicine
·
9
PDF
Two Methods, One Story? Comparing Results of a Choice Experiment and Multidimensional Thresholding From a Clinician Preference Study in Aneurysmal Subarachnoid Hemorrhage
2023
·
Sebastian Heidenreich
, Myrto Trapali
, et al.
·
Value in Health
·
7
PDF
Meaningful Within-Patient Change on the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ): Analysis of Phase III Clinical Trial Data of Daridorexant
2023
·
Andrea Phillips-Beyer
, Ariane K. Kawata
, et al.
·
Pharmaceutical Medicine
·
7
PDF
Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)
2023
·
Stacie Hudgens
, Andrea Phillips-Beyer
, et al.
·
Advances in Therapy
·
3
PDF
A patient-centric benefit-risk assessment of daridorexant for the treatment of insomnia disorder using patient preference data collected in two phase 3 clinical trials
2025
·
Sebastian Heidenreich
, Melissa Ross
, et al.
·
Sleep Epidemiology
·
2
Clinicians' preferences for managing aneurysmal subarachnoid hemorrhage using endothelin receptor antagonists
2023
·
Sebastian Heidenreich
, Myrto Trapali
, et al.
·
Frontiers in Neurology
·
2
PDF
The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial
2022
·
Robert J Fox
, Tommi Tervonen
, et al.
·
Multiple Sclerosis Journal
·
2
0455 The Insomnia Daytime Symptoms and Impacts Questionnaire: An Analysis of Clinically Meaningful Change Using Phase 3 Clinical Trial Data
2022
·
Andrea Phillips-Beyer
, Ariane Kawata
, et al.
·
SLEEP
·
2
PDF
Disease features at diagnosis and changes in disease course severity among commercially insured patients with childhood-onset compared with adult-onset systemic lupus erythematosus
2025
·
Michael E Stokes
, Andrea Phillips-Beyer
, et al.
·
Lupus
·
1
Patients’ Preferences for Systemic Lupus Erythematosus Treatments—A Discrete Choice Experiment
2024
·
Hannah Collacott
, Andrea Phillips-Beyer
, et al.
·
Patient
·
1
0384 Assessing the content validity of the IDSIQ through cognitive interviews in individuals with comorbid insomnia and nocturia
2023
·
Andrea Phillips-Beyer
, Antonio Olivieri
, et al.
·
SLEEP
·
1
PDF
0458 The Sleep Diary Questionnaire: An Analysis of Meaningful Change in Subjective Total Sleep Time Using Phase 2 and Phase 3 Clinical Trial Data
2022
·
Andrea Phillips-Beyer
, Ariane Kawata
, et al.
·
SLEEP
·
1
PDF
Insomnia Daytime Symptoms and Impacts Questionnaire
2021
·
Stacie Hudgens
, Andrea Phillips‑Beyer
, et al.
·
PsycTESTS Dataset
·
1
Confirming content validity of The Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) among adults with insomnia in four European countries
2025
·
Andrea Phillips-Beyer
, Ariane K. Kawata
, et al.
·
Journal of Patient-Reported Outcomes
PDF
Confirming content validity of The Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) among adults with insomnia in four European countries
2025
·
Phillips-Beyer, Andrea
, Kawata, Ariane K.
, et al.
·
Figshare
Additional file 1 of Confirming content validity of The Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) among adults with insomnia in four European countries
2025
·
Phillips-Beyer, Andrea
, Kawata, Ariane K.
, et al.
·
Figshare
0406 Impact of comorbid insomnia and nocturia on subjects' lives as assessed through a concept elicitation study
2023
·
Andrea Phillips-Beyer
, Antonio Olivieri
, et al.
·
SLEEP
PDF
A benefit-risk assessment of daridorexant for the treatment of insomnia using patient preference data from two phase 3 trials
2022
·
S. Heidenreich
, A. Phillips-Beyer
, et al.
·
Sleep Medicine
Pos0752 Disease Features at Diagnosis and Changes in Disease Course Severity Among Patients With Childhood-onset Compared to Adult-onset Systemic Lupus Erythematosus
2022
·
A. Phillips-Beyer
, Q. Li
, et al.
·
Annals of the Rheumatic Diseases
PDF
Pos0086-pare Patient Preferences for Systemic Lupus Erythematosus Treatments: a Discrete Choice Experiment
2022
·
H. Collacott
, A. Phillips-Beyer
, et al.
·
Annals of the Rheumatic Diseases
PDF
Pos0192 Impact of Corticosteroid Discontinuation on Symptom Control in Patients With Systemic Lupus Erythematosus
2022
·
A. Phillips-Beyer
, Q. Li
, et al.
·
Annals of the Rheumatic Diseases
PDF
Show more works
View as search
Works count:
33
Citation count:
149
H-index:
7
I10-index:
4
Year
Topic
Type
